We are three senior bioinformaticians with complementary expertise in molecular biology, advanced bioinformatics, and AI modeling. With over a decade of experience across academia and industry, we co-created Sycomia to meet the growing demand for complex Omics data analysis.
We support biological projects from defining research questions to data analysis, interpretation, and integration.
LOUIS CHAUVIERE, PhD
Louis Chauvière is an expert in molecular biology and bioinformatics. After earning two Master’s degrees in these fields, he completed a Ph.D. in an Epigenetics laboratory at Université Paris Cité, where he studied X chromosome inactivation in humans. With over ten years of experience in academic research, hospitals, and CROs, Louis has designed and developed numerous Omics data analysis strategies and pipelines. He has deep expertise in single-cell and RNA-seq data analysis, from experimental design to biological interpretation. By co-founding Sycomia, he now brings this high-level expertise to your projects, offering tailored and scientifically rigorous solutions for complex data analysis challenges.
Louis Chauvière is an expert in molecular biology and bioinformatics. After earning two Master’s degrees in these fields, he completed a Ph.D. in an Epigenetics laboratory at Université Paris Cité, where he studied X chromosome inactivation in humans. With over ten years of experience in academic research, hospitals, and CROs, Louis has designed and developed numerous Omics data analysis strategies and pipelines. He has deep expertise in single-cell and RNA-seq data analysis, from experimental design to biological interpretation. By co-founding Sycomia, he now brings this high-level expertise to your projects, offering tailored and scientifically rigorous solutions for complex data analysis challenges.
I will be your key contact for designing data analysis strategies tailored to your projects.
FLORENT TESSIER, MSc
Having collaborated with hospitals, academic research groups, and major pharmaceutical companies, Florent Tessier brings over ten years of experience across both public and private sectors. Holding a Master’s degree in bioinformatics (Université Paris-Saclay/École Polytechnique), he is a co-founder of Sycomia, where he is responsible for developing analysis pipelines and executing bioinformatics workflows across a variety of projects. Having worked across nearly all major omics technologies from genomics to proteomics, he offers broad, hands-on expertise in the field.
Having collaborated with hospitals, academic research groups, and major pharmaceutical companies, Florent Tessier brings over ten years of experience across both public and private sectors. Holding a Master’s degree in bioinformatics (Université Paris-Saclay/École Polytechnique), he is a co-founder of Sycomia, where he is responsible for developing analysis pipelines and executing bioinformatics workflows across a variety of projects. Having worked across nearly all major omics technologies from genomics to proteomics, he offers broad, hands-on expertise in the field.
I will deliver fast, accurate, and reliable results for your analyses.
NICOLAS SCALZITTI, PhD
Nicolas Scalzitti is a senior bioinformatician with expertise in biological data analysis and artificial intelligence. After a Master’s in bioinformatics, he completed a Ph.D. at the University of Strasbourg on AI-based genome annotation strategies. He has taught computer science courses, particularly Python programming and databases, and later joined a U.S. research lab to develop AI tools for designing therapeutic peptides. In 2025, he co-founded Sycomia to promote his values: scientific rigor, complete transparency, and a commitment to innovation.
Nicolas Scalzitti is a senior bioinformatician with expertise in biological data analysis and artificial intelligence. After a Master’s in bioinformatics, he completed a Ph.D. at the University of Strasbourg on AI-based genome annotation strategies. He has taught computer science courses, particularly Python programming and databases, and later joined a U.S. research lab to develop AI tools for designing therapeutic peptides. In 2025, he co-founded Sycomia to promote his values: scientific rigor, complete transparency, and a commitment to innovation.
Staying up to date with the latest technologies, I will work with you to design cutting-edge AI solutions.